Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raghavan Varadarajan

Showing results (141-150 of 145) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 145 results.
Nature Communications|July 3, 2024
A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidasesZaolan Liang, Xia Lin, Lihong Sun, et al.
Science Immunology|July 22, 2022
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaquesAnusmita Sahoo, Andrew T Jones, Narayanaiah Cheedarla, et al.
Vaccine|June 20, 2025
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnelMargarita Mishina, Weiping Cao, Zachary Ende, et al.
Frontiers in Immunology|December 27, 2021
A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of ConcernShahbaz Ahmed, Mohammad Suhail Khan, Savitha Gayathri, et al.
ACS Infectious Diseases|July 14, 2021
Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain DerivativeSameer Kumar Malladi, Unnatiben Rajeshbhai Patel, Raju S Rajmani, et al.
Pageof 15

Showing results (141-150 of 145) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 145 results.
Nature Communications|July 3, 2024
A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidasesZaolan Liang, Xia Lin, Lihong Sun, et al.
Science Immunology|July 22, 2022
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaquesAnusmita Sahoo, Andrew T Jones, Narayanaiah Cheedarla, et al.
Vaccine|June 20, 2025
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnelMargarita Mishina, Weiping Cao, Zachary Ende, et al.
Frontiers in Immunology|December 27, 2021
A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of ConcernShahbaz Ahmed, Mohammad Suhail Khan, Savitha Gayathri, et al.
ACS Infectious Diseases|July 14, 2021
Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain DerivativeSameer Kumar Malladi, Unnatiben Rajeshbhai Patel, Raju S Rajmani, et al.
Pageof 15